Antibiotic options for patients with a severe penicillin allergy exclude all penicillin and often beta-lactam antibiotics due to potential cross-reactivity risks. In such cases, alternative non-beta-lactam antibiotics should be considered based on the infection being treated and the susceptibility profile.
Specifically, for respiratory infections such as bronchiectasis, where penicillin or amoxicillin would normally be first-line, NICE recommends using macrolides like clarithromycin or erythromycin, or doxycycline for adults with a penicillin allergy NICE CKS.
For severe infections such as bacterial meningitis caused by Neisseria meningitidis or other common pathogens where ceftriaxone or cefotaxime (cephalosporins) would be used, allergy history must be carefully considered. If the penicillin allergy reaction was not severe, these cephalosporins may still be considered. However, for severe penicillin allergies, alternative regimens involve co-trimoxazole and chloramphenicol for infections with risk of Listeria monocytogenes, or chloramphenicol alone for other pathogens NICE NG240.
Non-beta-lactam antibiotics recommended in penicillin-allergic patients include macrolides (e.g., erythromycin, clarithromycin), tetracyclines (e.g., doxycycline), co-trimoxazole, and chloramphenicol depending on the infection and severity of allergy NICE CKS,NICE NG240.
Due to the risk of severe hypersensitivity reactions, assessed as more likely in severe penicillin allergy (including anaphylaxis), direct treatment with penicillins or closely related beta-lactams should be avoided, and allergy specialist consultation is advised to confirm allergy status and guide antibiotic choice NICE CG183.
Given diagnostic uncertainties, and risks of undertreatment or broad-spectrum antibiotic overuse in patients with reported penicillin allergy, careful risk stratification and allergy assessment are crucial. Delabeling false penicillin allergies where safe can improve antibiotic options NICE CG183,Kildonaviciute et al. 2026.
Key References
- SmPC: Phenoxymethylpenicillin Sugar Free 125mg / 5ml Powder for Oral Solution
- SmPC: Phenoxymethylpenicillin Sugar Free 250mg / 5ml Powder for Oral Solution
- SmPC: Phenoxymethylpenicillin 250 mg Tablets (PL 43461/0073)(POM)
- SmPC: Phenoxymethylpenicillin 250mg Film-coated Tablets
- NICE CG183: Drug allergy: diagnosis and management
- NICE CKS: Bronchiectasis
- NICE NG240: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management
- NICE CKS: Food allergy
- NICE CKS: Diarrhoea - antibiotic associated
- NICE CKS: Adverse drug reactions
- (Davis et al., 2026): Outcomes in hospitalised patients with penicillin allergy: a systematic review and meta-analysis protocol.
- (Clayton et al., 2026): Parental awareness and management of antibiotic side effects and allergies in children and young people: a UK survey.
- (Kildonaviciute et al., 2026): What are patients' and healthcare professionals' views on managing penicillin allergy? A qualitative evidence synthesis.